IC Value
About Us
Editorial Board
Contact Us

Mild cognitive impairment: a comprehensive review

Authors:V N Mishra, V Singh
Int J Biol Med Res. 2019; 10(2): 6773-6781  |  PDF File


Background: Mild cognitive impairment (MCI) is an intermediate stage between normal cognitive alterations associated with aging and dementia. MCI individuals identified as having a faster rate of progression to dementias. Main body: There is different type of risk factors for MCI progression include greater cognitive deficits at baseline, ApoE4 carrier status, brain volume changes, cerebrospinal fluid (CSF) changes, and the presence of behavioral and psychological symptoms. Refinements in the diagnostic criteria for MCI and the identification of biomarkers result in the development of possible prevention and treatment strategies. Conclusion: In the present study, we summarize the epidemiology, neuropsychological aspect, management and preventive treatment for MCI. As, better understanding of MCI could help in minimizing risk of MCI.